ArticleFrontiers in cellular and infection microbiology2022

A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.

Xiaofeng Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.